0000000000784626

AUTHOR

B Paris

showing 2 related works from this author

A global experiment on motivating social distancing during the COVID-19 pandemic

2022

Significance\ud \ud Communicating in ways that motivate engagement in social distancing remains a critical global public health priority during the COVID-19 pandemic. This study tested motivational qualities of messages about social distancing (those that promoted choice and agency vs. those that were forceful and shaming) in 25,718 people in 89 countries. The autonomy-supportive message decreased feelings of defying social distancing recommendations relative to the controlling message, and the controlling message increased controlled motivation, a less effective form of motivation, relative to no message. Message type did not impact intentions to socially distance, but people’s existing mo…

behavior changeCoronavirus disease 2019 (COVID-19)230 Affective NeuroscienceINTENTIONSL400self-determination theoryPhysical DistancingSocial SciencesIntention:Ciências Sociais::Psicologia [Domínio/Área Científica]FATIGUEmotivationPARENTAL PROHIBITIONSDG 3 - Good Health and Well-beingPandemicHumanshealth communicationMESSAGESSociologyPandemicsMETAANALYSISbehavior change ; motivation ; health communication ; COVID-19 ; self-determination theoryBehaviour Change and Well-beingMultidisciplinarybusiness.industrySocial distanceCOVID-19Public relationsbehavior change; motivation; health communication; COVID-19; self-determination theoryCOVID-19; behavior change; health communication; motivation; self-determination theory; Humans; Intention; COVID-19; Motivation; Pandemics; Physical Distancing/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingINTERNALIZATIONbusinessBEHAVIOR
researchProduct

Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combin…

2010

There is a lack of information on the characteristics of patients with chronic hepatitis C virus infection (HCV) who fail to respond to antiviral treatment. We studied HCV-positive subjects with chronic liver diseases treated with pegylated-interferon (PEG-IFN) and ribavirin (RBV) who failed to clear HCV in routine clinical practice. A total of 2150 consecutive adult patients treated with PEG-IFN plus RBV therapy in 46 Italian centres between 1 July 2004, and 30 June 2005, were studied. Of the 2150 patients, 923 (42.9%) (M/F 585/335, mean age 54.8 years) failed to achieve a serum HCV-RNA clearance. Of these 923 patients, 429 (46.5%) were nonresponders, 298 (32.3%) relapsers, 168 (18.2%) dro…

AdultMalenon-responders.relapserGenotypebody mass index; cirrhosis; hepatitis c virus; nonresponder; pegylated-interferon; relapserInfectious Diseasebody mass indexHepacivirusvirusInterferon alpha-2Antiviral AgentsPolyethylene GlycolPolyethylene GlycolsMedication Adherencebody mass index; cirrhosis; hepatitis C; virus; nonresponder; pegylated-interferon; relapserRisk FactorsRetrospective StudienonresponderVirologyRibavirinHumansAge FactorTreatment FailureRetrospective StudiesAgedAntiviral AgentSettore MED/12 - GastroenterologiaHCV; Antiviral therapy; Body mass index; Cirrhosis; Hepatitis C virus; Nonresponder; Pegylated-interferon; RelapserCirrhosiHepaciviruHepatologyRisk FactorcirrhosisAge FactorsInterferon-alphahepatitis c virusHepatitis C ChronicMiddle AgedRecombinant ProteinRecombinant ProteinsItalyRNA ViralFemalehepatitis Cpegylated-interferonHepatitis C viruHuman
researchProduct